Development of high-resolution magnetic resonance imaging (MRI) techniques in recent years has made it possible to directly assess plaque burden and composition. 1e9 Prospective MRI studies of carotid lesions 10e13 offer compelling evidence that high-risk plaque features, such as, thin or ruptured cap, intraplaque hemorrhage (IPH), presence of lipid-rich necrotic core (LRNC), and increased LRNC volume, strongly associate with clinical cerebrovascular events as well as coronary heart disease events. We designed a multicenter carotid MRI study in the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) 14, 15 to directly assess atherosclerotic plaque burden and tissue contents in patients with established vascular disease and well-controlled low-density lipoprotein cholesterol (LDL-C) levels and blood pressure, but, with elevated triglycerides and low level of high-density lipoprotein cholesterol (HDL-C). This report examines the association of clinical factors with the presence of baseline high-risk carotid plaque features as assessed by MRI in AIM-HIGH.
Methods
In a total of 3,414 AIM-HIGH participants, 447 were potentially available to be enrolled in the carotid MRI substudy at 21 clinical sites based on the recruitment dates a Division of Cardiology, and Departments of b Surgery and of each subject and the start of enrollment for the MRI substudy. The AIM-HIGH study enrolled men and women, aged !45, with atherogenic dyslipidemia consisting of low HDL-C levels (if off statin 40 mg/dl for men or 50 mg/dl for women), high triglycerides (if off statin 150 to 400 mg/ dl), and untreated LDL-C levels 180 mg/dl and documented clinically established atherosclerotic cardiovascular disease. Of these 447, there were 232 who met the inclusion or exclusion criteria-estimated glomerular filtration rate !60 ml/min/1.73 m 2 , had no contraindication to MRI, no history of claustrophobia, and consented to participate in the substudy. These subjects underwent the baseline carotid scan from February 2008 to May 2010 at 10 MRI centers. Details of site location, principal investigator, and coordinator information are listed in the Appendix. Two hundred fourteen subjects had acceptable image quality for assessment at baseline; as shown in Figure 1 . This study was approved by the AIM-HIGH Executive Committee and local institutional review board and/or research ethics committee at each participating clinical site. Separate signed informed consent was obtained from participants in this substudy.
The carotid MRI substudy in AIM-HIGH was a large multicenter investigation using either GE (GE Healthcare, Global Diagnostic Imaging, Pewaukee, Wisconsin) or Philips (Philips Healthcare, Andover, Massachusetts) 3T whole body scanners. A standardized carotid MRI scan protocol with multicontrast sequences as listed in Table 1 was developed by the University of Washington's Vascular Imaging Laboratory to achieve clear identification of carotid outer wall and lumen boundaries, as well as, plaque tissue contents. Subjects were placed in the supine position in the MRI scanner with the neck extended to bring the carotid arteries into a more superficial location relative to the skin. A custom-designed head holder was used to minimize movement. Two separate phased-array carotid coils were used to obtain a simultaneous bilateral scan. As listed in Table 1 , after the oblique scans, cross-sectional images with 2 mm thickness and a total coverage of 3.2 cm were obtained, centered at the common carotid bifurcation. A 20 ml (0.1 mmol/kg) bolus of gadolinium contrast material was administrated intravenously through a power injector for the dynamic contrast-enhanced MRI and postcontrast imaging. The T1-weighted (T1W) sequence was repeated between 5 and 7 minutes after contrast administration. The total scan time for each subject was <45 minutes per scan. The carotid artery with the thicker wall or larger plaque with less calcification on the baseline scan was assigned as the index side.
MRI personnel from all imaging sites participated in an MRI training session held by the core laboratory. They were instructed on study design, magnetic resonance protocol design, image acquisition, and identification and correction of imaging artifacts. After the training, each imaging site was required to perform a phantom scan, as well as, a scan of a volunteer using the study protocol. Adherence to protocol parameters, image quality, and presence of artifacts were assessed. Immediate feedback and technical support were provided to the site to remedy any protocol deviations and image quality issues.
All study scans were transferred to the core laboratory and reviewed for image quality and protocol deviations within 48 hours of the scan. Vessel Wall image quality was assessed based on a previous described 4-point scale. 16 Scans of inadequate quality were repeated. If the repeat scan did not qualify by image quality, then the subject was excluded from the study. Reviewers trained in carotid MRI analysis interpreted all images, blinded to subject information, therapy, and laboratory results. All images from time-of-flight, T1, proton density (PD), T2, 3D Magnetization Prepared Rapid Gradient Echo (MP-RAGE), and postcontrast T1 weightings were coregistered, using the common carotid bifurcation as a physical landmark. For each case, 2 reviewers reached consensus for the measurements made. Plaque components (LRNC, fibrous tissue, loose matrix, and calcification) were identified using previously published MRI criteria. 5 CASCADE (UW Radiology, Seattle, WA), 17 a customdesigned image analysis tool, was used to contour boundaries of the lumen, outer wall, and plaque components ( Figure 2 ). Volumes were derived by summing the contour areas across slices from the same vessel and multiplying the sum by the slice thickness (2 mm). The primary measure of plaque burden was percent wall volume (PWV), calculated using the following formula: (wall volume/total vessel volume) Â 100%. PWV adjusts for variation in artery size and is similar to percent atheroma volume described in the intravascular ultrasound literature. The percent volume of each component was calculated using the formula: (component volume/wall volume) Â 100%. In particular, percent LRNC volume was calculated using only the slices with LRNC present.
American Heart Association (AHA) lesion types were evaluated using previously published MRI-based criteria 7 : type I to II ¼ near-normal wall thickness; type III ¼ diffuse wall thickening or small eccentric plaque; type IV to V ¼ plaque with a necrotic core; type VI ¼ complex plaque with Peripheral Arterial Disease/Risk Factors of High-Risk Plaque Features in AIM-HIGHa possible surface defect, intraplaque hemorrhage, or mural thrombus; type VII ¼ calcified plaque; and type VIII ¼ fibrotic plaque without a necrotic core. The Carotid Atherosclerosis Score (CAS) for each plaque was computed with an adjustment to include AHA type-VI lesions in the highest risk category as previously described 18, 19 : CAS 1 (low risk) ¼ plaque with maximum wall thickness 2 mm; CAS 2 (medium to low risk) ¼ plaque with maximum percent LRNC (LRNC area/wall area) 20%; CAS 3 (medium to high risk) ¼ plaque with maximum percent LRNC 20% to 40%; CAS 4 (high risk) ¼ plaque with maximum percent LRNC >40% or AHA type-VI lesion.
Clinical characteristics of subjects in the MRI substudy were compared with those of the remainder of the AIM-HIGH cohort using Fisher's exact test and the MannWhitney test. Linear and logistic regression models were used to evaluate associations with continuous and binary plaque outcomes, respectively. Continuous variables were visually inspected using histograms and quantile-quantile plots to determine whether the distributional assumptions were appropriate. Highly right-skewed variables were logtransformed before inclusion in regression models. Throughout the regression analyses, continuous variables (outcome and independent variables) were standardized to have SD ¼ 1. For multivariate analysis, adjustments were made for age, gender, and PWV, and variables statistically significant after these adjustments were included in the final multivariate models. All statistical calculations were conducted with the R statistical software package (R Foundation for Statistical Computing, Vienna, Austria). 20 Throughout, 2-tailed tests were used with p <0.05 denoting statistical significance. Table 2 , compared with the rest of the AIM-HIGH cohort (n ¼ 3,200), the 214 subjects in the MRI substudy had the following statistically significant differences: they were younger (mean 61 vs 64 years, p <0.001), more likely to be nonwhite (12% vs 7%, p ¼ 0.02), more likely to have hypertension (83% vs 71%, p <0.001), less likely to be treated with statin for 1 year or longer (72% vs 82%, p ¼ 0.001), and less likely to have diabetes (25% vs 35%, p ¼ 0.004). They also had smaller body mass index (mean 30 vs 31 kg/m 2 , p ¼ 0.009) and lower triglycerides (median 158 vs 165 mg/dl, p ¼ 0.03).
Results

As listed in
From examination of the carotid MRI of the 214 subjects, mean PWV was 42 AE 7%, 77% of patients had carotid plaques, 52% were found to have lipid-containing plaques as shown in Figure 3 and 11% had advanced AHA type-VI lesions (Table 3) . Similarly, 26 subjects (12%) showed highrisk plaques with CAS ¼ 4. Figure 3 shows an MRI example of IPH with noticeable increased signal intensity on T1 and MP-RAGE.
Logistic regression analysis of AHA type-VI lesions are listed in Table 4 . Type-VI lesions were significantly associated with older age, a longer duration of statin treatment, cerebrovascular disease, and increased PWV in the univariate analysis. After adjusting for age, lipoprotein(a) level and PWV were significantly associated with increased likelihood of type-VI lesions, whereas, metabolic syndrome showed a negative association. Furthermore multivariate adjustments beyond age were not made because of the small number of type-VI lesions (n ¼ 23). Table 5 lists that presence of LRNC was significantly positively associated with male gender, white race, and PWV but significantly negatively associated with diabetes, body mass index, and HDL-C and ApoA1 levels in the univariate models (model 1) that included all the variables listed in Table 4 . After adjusting for age, gender, and PWV, diabetes and HDL-C remained statistically significant (model 2). The final multivariate model (model 3) showed that the risk of having LRNC was increased by 3.2-fold (odds ratio [OR]) in men, and by 3.8-fold with each 1 SD increase in PWV. The risk of having LRNC was 60% less in subjects with diabetes and 30% less with each 1 SD increase in HDL-C level. Percent LRNC was log-transformed for the regression analysis. In the 112 subjects (52%) with measurable LRNC, increased percent LRNC was significantly associated with older age, history of smoking, lower levels of triglycerides and ApoA1, and larger PWV (models 1 and 2) as listed in Table 5 . In the final multivariate model (model 3), which included adjustments for age, gender, and PWV, only ApoA1 (regression coefficient ¼ À0.20 per 1 SD increase, p ¼ 0.03) and PWV (regression coefficient ¼ 0.36 per 1 SD increase, p <0.001) remained significant.
Discussion
Among patients with established vascular disease, well treated for LDL-C and blood pressure in AIM-HIGH, 77% had carotid plaques, 52% of subjects had lipid-containing plaques, 11% had advanced AHA type-VI lesions with IPH, surface defect, or thrombus, and 12% showed high-risk plaques using CAS. However, the mean PWV was 42 AE 7% indicating the carotid stenosis was not severe. Subjects qualified for this study if they had a history of dyslipidemia and major vascular disease, not exclusively carotid atherosclerosis, and yet a significant proportion were found to have advanced carotid plaque features despite the previous use of statin and well-controlled LDL-C at baseline. These observations in plaque morphology suggest the study population was at increased residual cardiovascular risk and are consistent with significant cardiovascular event rate in AIM-HIGH. 15 These are also consistent with previous findings that high-risk plaque features are often seen in less severe stenosis. In an MRI angiography study 21 of carotid arteries with 0% stenosis, LRNC was present in 67.4% and IPH in 8.7% of nonocclusive lesions.
Histopathology studies demonstrate that women's atherosclerotic plaques are more prone to plaque erosion than frank rupture compared with men's. Furthermore, women more often have less calcification, less severe stenosis, and fewer inflammatory cells, but more smooth muscle cells and more eccentric coronary plaque than men. 22, 23 Gender difference in plaque characteristics was reported in a carotid MRI study of 131 patients (67 men, 64 women) with !50% asymptomatic carotid stenosis on duplex ultrasound. 24 The study showed that men had significantly higher frequency of LRNC compared with women (73% vs 50%, adjusted OR ¼ 3.66, p ¼ 0.01) and higher incidence of thin and/or ruptured fibrous cap (48% vs 17%, adjusted OR ¼ 4.41, p <0.01). Our study in subjects with less severe carotid stenosis also showed that male gender was significantly and independently associated with increased risk for presence of LRNC (OR ¼ 3.2, p ¼ 0.017).
The present study identified lipoprotein(a), HDL-C, or ApoA1 as independent factors associated with high-risk plaque features. The AIM-HIGH main trial demonstrated that lipoprotein(a) predicted residual cardiovascular events in subjects treated with statin alone or statin plus extendedrelease niacin. 25 These findings together indicate that lipoprotein(a) can be used for identification of high-risk populations and be a potential therapeutic target. Total cholesterol and LDL-C levels, which were correlated with presence of a lipid core and with greater lipid core volume in the Multi-Ethnic Study of Atherosclerosis 26 and the Atherosclerosis Risk in Communities Study (ARIC), 27 were not identified as factors associated with adverse plaque characteristics in the present study in subjects with established clinical vascular disease and well-treated LDL-C to a mean level <80 mg/dl. In contrast, lower HDL-C or ApoA1 are associated with presence of high-risk plaque features, which were also reported previously, 28, 29 however, whether HDL-C or ApoA1 increase lead to more stable plaques contributing to reduced cardiovascular events remains as a subject of interest.
Surprisingly, metabolic syndrome and diabetes appear to be negatively associated with high-risk plaque features in this analysis. Among the published studies, only ARIC 27 showed that the measured glucose and body mass index were inversely associated fibrous cap thickness. This unexpected result in the present study could be due to a combination of the following reasons, which could not be thoroughly investigated due to the small number of patients with high-risk features: (1) There were more women with metabolic syndrome or diabetes than men in the MRI substudy; the negative association may have been influenced by the gender difference in plaque features. (2) It is likely that high-risk diabetic or metabolic syndrome subjects with the greatest unstable plaque had an event that excluded them from participation in the study due to subject enrollment bias. (3) By chance, fewer diabetic subjects were enrolled in the MRI substudy compared with the main trial, which raises concern whether the negative association with diabetes and high-risk plaque features observed in the MRI substudy can be generalized to the larger study population. Furthermore, the estimated glomerular filtration rate requirement and willingness and ability to participate in the substudy might have selfselected the population with bias toward a healthier Continuous data are presented as mean AE SD, median and range in parenthesis.
Categorical data are presented as n (%). * AHA lesion types in order of increasing severity: I to II, III, VII, IV to V, and VI.
† As a percentage of the wall volume from locations with LRNC present.
group of subjects who were younger, with lower body mass index and fewer diabetics as described in Table 2 . A larger sample size might not make the substudy population more similar to the entire AIM-HIGH cohort due to the substudy selection bias. Finally, high-resolution MRI can accurately assess plaque burden and tissue contents 7e9 and identify high-risk plaque features that are associated with cardiovascular events.
10e13 To use MRI in multicenter investigation of atherosclerosis, critical elements are required: establishing a standardized scan protocol, technical training, image quality control, protocol adherence, and image analysis by a core laboratory. These were achieved in the AIM-HIGH carotid MRI substudy. A network with 21 clinical sites and 10 MRI scan facilities with GE or Philips 3T whole body scanners was successfully established through this substudy in the United States and Canada and is ready to be used for future clinical investigations in atherosclerosis.
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